Endoscopic ultrasound-guided radiofrequency ablation is a safe and efficient treatment of symptomatic insulinomas – A single centre experience of 14 patients

#4418

Introduction: The vast majority of insulinomas are benign and less than 20 mm. Surgery is considered as standard treatment, but complications are significant. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) represents a novel and minimally invasive approach.

Aim(s): To evaluate efficacy of EUS-RFA in localised insulinomas.

Materials and methods: We prospectively included patients diagnosed with insulinoma based on symptomatic hypoglycaemia with inappropriate high levels of insulin. Lesions considered for RFA treatment were localised biopsy proven pNEN (Ki-67

Conference:

Presenting Author: Andreassen M

Authors: Andreassen M, Kovacevic B, Brink L, Hansen C, Knigge U,

Keywords: Insulinoma, Benign, EUS, radiofrequency ablation,